BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27465994)

  • 21. Six Decades of History of Hypertension Research at the University of Toledo: Highlighting Pioneering Contributions in Biochemistry, Genetics, and Host-Microbiota Interactions.
    Gokula V; Terrero D; Joe B
    Curr Hypertens Rep; 2022 Dec; 24(12):669-685. PubMed ID: 36301488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SS
    Poudel B; Shields CA; Ekperikpe US; Brown AK; Travis OK; Maury JC; Fitzgerald S; Smith SV; Cornelius DC; Williams JM
    Am J Physiol Regul Integr Comp Physiol; 2022 Apr; 322(4):R299-R308. PubMed ID: 35107024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure.
    Brown AK; Nichols A; Coley CA; Ekperikpe US; McPherson KC; Shields CA; Poudel B; Cornelius DC; Williams JM
    Front Physiol; 2021; 12():765305. PubMed ID: 34975523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephron-deficient HSRA rats exhibit renal injury with age but have limited renal damage from streptozotocin-induced hyperglycemia.
    Cobb MB; Wu W; Attipoe EM; Johnson AC; Garrett MR
    Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1093-F1105. PubMed ID: 33843272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease.
    Pavlov TS; Palygin O; Isaeva E; Levchenko V; Khedr S; Blass G; Ilatovskaya DV; Cowley AW; Staruschenko A
    FASEB J; 2020 Oct; 34(10):13396-13408. PubMed ID: 32799394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.
    McPherson KC; Shields CA; Poudel B; Fizer B; Pennington A; Szabo-Johnson A; Thompson WL; Cornelius DC; Williams JM
    Am J Physiol Renal Physiol; 2019 Feb; 316(2):F316-F327. PubMed ID: 30539649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Causes and Potential Injurious Effects of Elevated Serum Leptin Levels in Chronic Kidney Disease Patients.
    Korczynska J; Czumaj A; Chmielewski M; Swierczynski J; Sledzinski T
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.
    McPherson KC; Taylor L; Johnson AC; Didion SP; Geurts AM; Garrett MR; Williams JM
    Am J Physiol Renal Physiol; 2016 Oct; 311(4):F793-F804. PubMed ID: 27465994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.
    McPherson KC; Shields CA; Poudel B; Johnson AC; Taylor L; Stubbs C; Nichols A; Cornelius DC; Garrett MR; Williams JM
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F911-F921. PubMed ID: 32068459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depletion of macrophages slows the early progression of renal injury in obese Dahl salt-sensitive leptin receptor mutant rats.
    Poudel B; Shields CA; Brown AK; Ekperikpe U; Johnson T; Cornelius DC; Williams JM
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1489-F1499. PubMed ID: 32390513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralizing MIP3
    Ekperikpe US; Poudel B; Shields CA; Mandal S; Cornelius DC; Williams JM
    J Pharmacol Exp Ther; 2023 Mar; 384(3):445-454. PubMed ID: 36507846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment With Gemfibrozil Prevents the Progression of Chronic Kidney Disease in Obese Dahl Salt-Sensitive Rats.
    Shields CA; Poudel B; McPherson KC; Brown AK; Ekperikpe US; Browning E; Sutton L; Cornelius DC; Williams JM
    Front Physiol; 2020; 11():566403. PubMed ID: 33071820
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.